Grail US Federal Trade Commission Begins Making the Case for Unwinding Illumina's Grail Purchase Premium The FTC claimed that Illumina can and will disadvantage Grail's rivals, but lawyers for the companies said the merger's benefits outweigh "speculative harms." European Commission to Investigate Illumina for Closing Grail Deal The new investigation will be separate from the ongoing Phase-II investigation into whether the deal violates Europe's merger control regulations. Illumina's 'Maverick' Move Secures Grail Deal But Risks Loom Premium Illumina faces potential fines in Europe for moving ahead with the deal but felt it had to act now in order to make sure it went through at all. Illumina Acquires Grail Despite Ongoing Regulatory Scrutiny Illumina said it will hold Grail as a separate company during the European Commission's ongoing regulatory review and abide by the outcome of the FTC's administrative trial. EU Regulators Change Deadline for Illumina-Grail Investigation The European Commission is reportedly waiting on Illumina to provide data and has not yet set a new deadline. Jul 22, 2021 European Commission Opens In-Depth Investigation of $8B Illumina-Grail Merger Jul 21, 2021 M&A in Genomics/MDx Sector Surges in H1 2021 Premium Jun 4, 2021 Grail Launches Galleri Cancer Early Detection Test, Backed by First PATHFINDER Interventional Data Premium Apr 29, 2021 Illumina Challenges European Commission's Jurisdiction Over Review of Grail Acquisition in EU General Court Apr 20, 2021 European Union to Review Illumina's Planned Grail Acquisition Under New Guidance Apr 15, 2021 Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches Premium Apr 2, 2021 Illumina Parries FTC Challenge to Grail Acquisition With Deals for Competing Customers Premium Mar 31, 2021 Illumina Upgraded to Buy by Canaccord Genuity Mar 30, 2021 FTC Moves to Block Illumina's $8B Grail Acquisition Feb 23, 2021 Grail Signs on Quest Diagnostics to Provide Phlebotomy for Cancer Detection Test Jan 11, 2021 Multi-Cancer Molecular Screening Assays Primed for Clinical Implementation in 2021 Premium Jan 11, 2021 Grail Inks Deals With Amgen, AstraZeneca, Bristol Myers Squibb for MRD Test Development Dec 28, 2020 M&A Deals in MDx/Omics Research Tools Space Fall 13 Percent in 2020 Premium Dec 22, 2020 Illumina Upgraded to Overweight by Piper Sandler Nov 30, 2020 Grail Inks Deal With UK National Health Service to Offer Cancer Screening Blood Test in 2021 Sep 24, 2020 Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test Sep 22, 2020 UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal Sep 21, 2020 Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider Premium Sep 21, 2020 JP Morgan Downgrades Illumina to Neutral on Grail Deal Sep 21, 2020 Illumina to Acquire Grail for $8B in Cash and Stock Load More Breaking News Ancient DNA Analysis Highlights Three Ancestral Populations in Japan FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.